Biblio

Export 1296 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2017
M. Yarchoan, James, B. D., Shah, R. C., Arvanitakis, Z., Wilson, R. S., Schneider, J., Bennett, D. A., and Arnold, S. E., “Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.”, J Alzheimers Dis, vol. 56, no. 2, pp. 699-706, 2017.
M. Yarchoan, James, B. D., Shah, R. C., Arvanitakis, Z., Wilson, R. S., Schneider, J., Bennett, D. A., and Arnold, S. E., “Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.”, J Alzheimers Dis, vol. 56, no. 2, pp. 699-706, 2017.
C. Kuate-Tegueu, Avila-Funes, J. - A., Simo, N., Le Goff, M., Amiéva, H., Dartigues, J. - F., and Tabue-Teguo, M., “Association of Gait Speed, Psychomotor Speed, and Dementia.”, J Alzheimers Dis, vol. 60, no. 2, pp. 585-592, 2017.
C. Kuate-Tegueu, Avila-Funes, J. - A., Simo, N., Le Goff, M., Amiéva, H., Dartigues, J. - F., and Tabue-Teguo, M., “Association of Gait Speed, Psychomotor Speed, and Dementia.”, J Alzheimers Dis, vol. 60, no. 2, pp. 585-592, 2017.
R. Stephen, Liu, Y., Ngandu, T., Rinne, J. O., Kemppainen, N., Parkkola, R., Laatikainen, T., Paajanen, T., Hänninen, T., Strandberg, T., Antikainen, R., Tuomilehto, J., Kiukaanniemi, S. Keinänen, Vanninen, R., Helisalmi, S., Levälahti, E., Kivipelto, M., Soininen, H., and Solomon, A., “Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.”, J Alzheimers Dis, vol. 59, no. 2, pp. 695-705, 2017.
K. E. McLimans and Willette, A. A., “Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.”, J Alzheimers Dis, vol. 56, no. 1, pp. 403-413, 2017.
A. V. Ivachtchenko, Okun, I., Aladinskiy, V., Ivanenkov, Y., Koryakova, A., Karapetyan, R., Mitkin, O., Salimov, R., and Ivashchenko, A., “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
G. Cebers, Alexander, R. C., Haeberlein, S. Budd, Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L., Russell, M., Maltby, J., Eketjäll, S., and Kugler, A. R., “AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
S. Sindi, Ngandu, T., Hovatta, I., Kåreholt, I., Antikainen, R., Hänninen, T., Levälahti, E., Laatikainen, T., Lindström, J., Paajanen, T., Peltonen, M., Khalsa, D. Singh, Wolozin, B., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Solomon, A., “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
C. Robb, Udeh-Momoh, C., Wagenpfeil, S., Schöpe, J., Alexopoulos, P., and Perneczky, R., “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
C. Robb, Udeh-Momoh, C., Wagenpfeil, S., Schöpe, J., Alexopoulos, P., and Perneczky, R., “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
Y. Kuttner-Hirshler, Venkatasubramanian, P. N., Apolinario, J., Bonds, J., Wyrwicz, A. M., and Lazarov, O., “Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 60, no. 3, pp. 949-958, 2017.
E. D. Huey, Lee, S., Cheran, G., Grafman, J., and Devanand, D. P., “Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 551-558, 2017.
S. Pandya, Kuceyeski, A., and Raj, A., “The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1639-1657, 2017.
T. J. Nelson, Sun, M. - K., Lim, C., Sen, A., Khan, T., Chirila, F. V., and Alkon, D. L., “Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials.”, J Alzheimers Dis, vol. 58, no. 2, pp. 521-535, 2017.
E. Pongan, Tillmann, B., Leveque, Y., Trombert, B., Getenet, J. Claude, Auguste, N., Dauphinot, V., Haouari, H. El, Navez, M., Dorey, J. - M., Krolak-Salmon, P., Laurent, B., and Rouch, I., “Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 2, pp. 663-677, 2017.
N. Ketter, H Brashear, R., Bogert, J., Di, J., Miaux, Y., Gass, A., Purcell, D. D., Barkhof, F., and H Arrighi, M., “Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 57, no. 2, pp. 557-573, 2017.
E. Niemantsverdriet, Ottoy, J., Somers, C., De Roeck, E., Struyfs, H., Soetewey, F., Verhaeghe, J., Van den Bossche, T., Van Mossevelde, S., Goeman, J., De Deyn, P. Paul, Mariën, P., Versijpt, J., Sleegers, K., Van Broeckhoven, C., Wyffels, L., Albert, A., Ceyssens, S., Stroobants, S., Staelens, S., Bjerke, M., and Engelborghs, S., “The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
C. Gervaise-Henry, Watfa, G., Albuisson, E., Kolodziej, A., Dousset, B., Olivier, J. - L., Jonveaux, T. Rivasseau, and Malaplate-Armand, C., “Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.”, J Alzheimers Dis, vol. 57, no. 2, pp. 437-445, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H., “Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
E. T. Ighodaro, Nelson, P. T., Kukull, W. A., Schmitt, F. A., Abner, E. L., Caban-Holt, A., Bardach, S. H., Hord, D. C., Glover, C. M., Jicha, G. A., Van Eldik, L. J., Byrd, A. X., and Fernander, A., “Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.”, J Alzheimers Dis, vol. 60, no. 1, pp. 1-10, 2017.
I. Apostolova, Lange, C., Roberts, A., Igel, H. Joachim, Mäurer, A., Liese, S., Estrella, M., Prasad, V., Stechl, E., Lämmler, G., Steinhagen-Thiessen, E., and Buchert, R., “Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.”, J Alzheimers Dis, vol. 56, no. 1, pp. 197-204, 2017.
D. P. Devanand, Lentz, C., Chunga, R. E., Ciarleglio, A., Scodes, J. M., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Bell, K., and Pelton, G. H., “Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1525-1531, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., “Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.

Pages